SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-470970
Filing Date
2012-11-14
Accepted
2012-11-14 21:41:34
Documents
8
Period of Report
2012-11-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d437934d8k.htm 8-K 57660
2 EX-3.1 d437934dex31.htm EX-3.1 67909
3 EX-10.1 d437934dex101.htm EX-10.1 121493
4 EX-10.2 d437934dex102.htm EX-10.2 64827
5 EX-10.3 d437934dex103.htm EX-10.3 62377
6 EX-10.4 d437934dex104.htm EX-10.4 20308
7 EX-10.5 d437934dex105.htm EX-10.5 12965
8 GRAPHIC g437934g79d29.jpg GRAPHIC 5534
  Complete submission text file 0001193125-12-470970.txt   416894
Mailing Address 167 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 167 SIDNEY STREET CAMBRIDGE MA 02139 6176795500
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 121206676
SIC: 2836 Biological Products, (No Diagnostic Substances)